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Conclusion: TAVI with direct aortic approach seems safe and feasible also in redo
patients offering a new attractive option to treat selected high-risk patients with severe
aortic stenosis and peripheral vasculopathy, and emerged as a valuable alternative to
trans-apical procedures
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Multi-Slice Computed Tomography: a New Gold Standard for Valve Sizing and
Prevention of Aortic Regurgitation in Patients Referred forTranscatheter
Aortic Valve Implantation?
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Ramjankhan, Gertjan Sieswerda, Michiel Voskuil, Marieke Hillaert, Lex van
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Background: Moderate to massive aortic regurgitation (AR) is occurring in 30% of
cases after TAVI. Pre-procedural assessment of aortic annulus diameter is key for
appropriate sizing of the prosthesis and prevention of AR. Transoesophageal
echocardiography (TEE) is currently the method of choice in this setting. The value of
multi-slice computed tomography (MSCT) is unknown.
Methods: In 70 consecutive patients, implantation of the SAPIEN XT prosthesis was
performed using TEE as recommended: 1) When annulus was > 24.5mm the procedure
was not performed; 2) The cut-off point of 21.5m was used to choose between a 23mm
or a 26mm prosthesis. Annulus diameter by MSCT was measured in all patients pre-
procedural. For each modality, TEE and MSCT, the “sizing index” was defined as the
ratio “prosthesis diameter/annulus diameter”. Aortic regurgitation was evaluated by
echocardiography performed at discharge and graded as: 0=none/trace, 1=mild,
2=moderate, 3=severe and 4=massive.
Results: Moderate-to-massive AR was observed in 20/70 (28%) patients, including
6/70 (8.5%) with a severe/massive AR. Annulus diameter was significantly larger by
MSCT than by TEE (25.3±2.7vs 22.4±1.9, p=0.001). A significant but weak correlation
was found between these 2 measurements (r=0.42; p=0.001). No significant correlation
was found between annulus diameter by TEE and the degree of AR or between the
“sizing index” by TEE and AR. A significant and inverse correlation was found
between annulus diameter by MSCT and the degree of AR (R=0.51; p=0.001). The
inverse correlation between the “sizing index” by MSCT and AR was higher (R=0.62;
p=0.0001). In the 17 patients with a “sizing index” by MSCT≤1; 6 had a moderate AR
(35%) and 6 had a severe/massive AR (35%). In the 53 patients with a “sizing index”
by MSCT >1; 8 had a moderate AR (15%) and none had severe/massive AR (0%). The
difference was highly significant (p=0.0001).
Conclusion: Once patients with a very large annulus by TEE (>24.5mm) have been
excluded, TEE is of no use to predict AR after TAVI. By contrast MSCT has a good
ability to predict such complication. In addition our analysis suggests that a simple
approach of choosing a prosthesis diameter > annulus diameter by MSCT should
eliminate the risk of severe/massive AR and drastically reduce the risk of moderate
AR.
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Background: Tansaortic (TAo) approach is another emerging approach for
implantation of the Edwards Sapien transcatheter valve through a partial upper
sternotomy. ‘Porcelain aorta’ is often considered a contraindication for this approach.
TAo procedure requires a relatively small calcium free area in the distal ascending
aorta ≥5 centimeters from the aortic annulus-‘TAo zone’ (Figure 1). Hence
conventional definition of ‘Porcelain aorta’ may not apply to TAo approach.
Methods: 212 patients (11 Porcelain aorta) underwent TAVR in our institution till June
2011. The CT scans were retrospectively analyzed with 3-D reconstruction for
distribution of calcium in the ascending aorta using FDA approved Osirix software
with special attention to the ‘TAo zone’ (Figure 2).
Results: 211 Patients including 10 Porcelain aorta patients had a calcium free ‘TAo
zone’ in the ascending aorta. Only one patient with diffuse distribution of calcium
would be a contraindication for this procedure.3/10 underwent TAo procedure with no
TIA or stroke postoperatively. 3-D reconstruction data correlated very well with the
operative findings.
‘TAo Zone’ in the distal ascending aorta
3-D reconstruction demonstrates ‘TAo zone’ free of calcium in a patient identified as
porcelain aorta
Conclusion: Conventional definition of Porcelain aorta should not be considered a
contraindication for performing a Transaortic procedure.
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Beyond the short-term: Clinical Outcome and Valve Performance Two Years
after Transcatheter Aortic Valve Implantation in 227 Patients
Sabine Bleiziffer, Domenico Mazzitelli, Anke Opitz, Ina Hettich, Yacine Elhmidi,
Hendrik Ruge, Nicolo Piazza, Rüdiger Lange
German heart center, department of cardiovascular surgery. Munich, Munich,
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Background: Though procedural feasibility of transcatheter aortic valve implantation
(TAVI) has been shown by multiple groups, longer-term data are rare. We report on
two-year-follow-up clinical and echocardiographic results after TAVI in 227 patients.
Methods: Of 580 non-surgical candidates who underwent TAVI for symptomatic high-
grade aortic stenosis, 227 have completed two-year-follow-up. Mean age was 81±7y,
59% were female, mean EuroScore and mean STS score were 21±14% and 7±5%, and
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